De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system
- 1 April 2004
- journal article
- review article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (4) , 385-395
- https://doi.org/10.1016/j.healun.2003.08.028
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesisTransplantation, 2002
- Correlation of anti-vimentin antibodies with acute and chronic rejection following cardiac transplantationHuman Immunology, 2002
- COMPLEMENT ACTIVATION PRODUCTS IN PLASMA AFTER HEART TRANSPLANTATION IN HUMANS1Transplantation, 2001
- Role of antibodies in rejectionCurrent Opinion in Organ Transplantation, 1999
- Solubilized HLA class I antigen enzyme-linked immunoassay to identify HLA-typing reagentsHuman Immunology, 1994
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993
- ENZYME-LINKED IMMUNOASSAY FOR ANTI-HLA ANTIBODIES—AN ALTERNATIVE TO PANEL STUDIES BY LYMPHOCYTOTOXICITYTransplantation, 1993
- Vascular deposition of complement-split products in kidney allografts with cell-mediated rejectionClinical and Experimental Immunology, 1991
- Anti-Heart Antibodies in Cardiac Allograft RecipientsInternational Archives of Allergy and Immunology, 1984
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981